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Abstract
In the rat, the decidual tissue is an important component for maternal recognition of pregnancy.
Decidualization can be induced by either the implantation of the blastocyst or by artificial stimuli.
The process of decidua formation or decidualization, is characterized by growth and differentiation
of endometrial stromal cells. Prostaglandin F2alpha (PGF2α) has been shown to be involved in
inhibition of implantation, alteration of embryo development, induction of luteal regression, and the
mediation of pregnancy loss induced by microorganism infections. In order to establish a direct role
for PGF2α in decidual function, we have evaluated its effects on the expression of an extensive
array of genes using primary decidual cell culture. Upon treatment with PGF2α sixty genes were
significantly down-regulated whereas only six genes were up-regulated (from a total of 1176 genes
studied). Interestingly, the majority of the genes inhibited by PGF2α are either directly or indirectly
involved in the turnover of the extracellular matrix (ECM). Genes such as gelatinase A (MMP2),
cathepsin L, tissue inhibitor metalloproteinases 2 (TIMP2) and 3 (TIMP3), plasminogen activator
inhibitor1 (PAI1), tissue type plasminogen activator (tPA), urokinase plasminogen activator (tPA),
endothelin 1, calponin, carboxypeptidase D and calponin acidic were down regulated. The opposite
effect was observed for prostromelysin 53 kDa (proMMP3), plasma proteinase I alpha and alpha 1
antiproteinase, all of which were significantly up-regulated by PGF2α. The results strongly suggest
that the abortificient role of elevated levels of PGF2α after implantation is due, in large part, to
inhibition of genes involved in the normal turnover of the extracellular matrix necessary for
decidual formation.
Background
The establishment of successful pregnancy requires a pro-
found reorganization of uterine tissues. Rapid growth and
differentiation of the endometrial stroma is the earliest
and most striking event in pregnancy. Differentiation of
stromal cells leads to the formation of unique cells,
termed decidual cells, which differ greatly from the origi-
nal stromal cells [1]. The decidua is an important compo-
nent in the maternal recognition of pregnancy and can be
induced by either the implantation of the blastocyst or by
artificial stimuli. An interesting feature is that – the growth
and differentiation of the endometrial cells – occurs dif-
ferently in different regions of the uterus [1]. Mesometrial
decidual cells are formed after the antimesometrial
decidua and their death takes place after antimesometrial
cell degeneration. Regression of the decidual cells appears
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to be controlled by an intrinsic cell death program of
apoptosis, which takes place after day 10 of pregnancy in
the antimesometrial region first, followed by the mesome-
trial region [2].
Prostaglandin F2α can induce different biological actions
at the beginning and at the end of pregnancy. PGF2α, Pros-
taglandin E2 (PGE2), and 6-keto-PGF1α are produced by
the pregnant uterus [3]. An increase of uterine PGE2 and
PGF2α is observed on day 5 of pregnancy, allowing the
decidualization process to take place. When embryo
access to the uterus is impaired, production of prostaglan-
dins (PGE2 and PGF2α) is suppressed [4]. During postim-
plantation, PGE2 returns to the original preimplantation
levels, but PGF2α decreases [4]. Whereas PGF2α contrib-
utes to the process of decidualization, implantation and
recognition of pregnancy. An increase in PGF2α over cer-
tain values can terminate pregnancy [6]. A high level of
PGF2α is known to induce inhibition of implantation,
alteration of embryo development, and induction of
luteal regression [5]. During infection, an inflammatory
response mediated by cytokines can be generated [7]. This
release of PGF2α can induce premature uterine contraction
and premature labor [8]. Depending on which stage of
pregnancy an increase of PGF2α secretion occurs, it can
alter implantation, induce abortion or even embriole-
thality [7,8]. Because an increase in PGF2α levels after
implantation can be detrimental for the progression of
pregnancy, the aim of this investigation was to determine
whether PGF2α affects directly decidual cells and leads to
disturbance in the expression of genes crucial for decidual
survival.
Methods
Animal model
Pseudopregnancy was induced by mating Holtzman
Sprague Dawley female rats with vasectomized male rats.
The day a vaginal plug was found was designated day 1 of
pseudopregnancy. Decidualization of the uterine
endometrium was induced by scratching the antimesome-
trial surface with a hooked needle on day 5 of pseudopreg-
nancy under ether anaesthesia. Animals were housed in a
controlled environment (22–24°C) and kept under con-
trolled conditions (lights on; 0500–1900 hrs) with free
access to standard rat chow and water. The University of
Illinois at Chicago animal care and use committee
approved the animal care and handling.
Primary decidual cell culture and hormone treatment
For each experiment 15 pseudopregnant rats were used.
Decidual cells were isolated as previously described [9].
Cells were pooled and seeded into six-well plates (1.4 ×
106 cells/ well). They were allowed to attach 3–4 hrs
before washing in PBS to remove erythrocytes. Cells were
incubated in RPMI 1640 without phenol red (Mediatech,
Whashington DC), containing 1% CD-FBS (HyClone
Laboratories Inc, Logan, UT), and treated with or without
high levels (5 µM [10,11]) of PFG2α (Sigma, St. Louis,
MO) for 12 hr). After incubation, the cells were harvested
in cold PBS, quick frozen in liquid nitrogen and kept at -
80 C until RNA isolation.
Gene identification by cDNA array
Total RNA was isolated from primary decidual cells (PDC)
by using a RNAII isolation kit (Clontech, Palo Alto, CA),
following the manufacture's instructions. RNA isolated
from wells treated with either PGF2α  or vehicle were
pooled independently and subjected to cDNA array.
cDNA probes were generated from 4 µg of total RNA in a
reverse transcriptase reaction using a mix of dATP, dTTP
and dGTP (Takara Biomedicals, Shiga, Japan) plus [α32P]-
dCTP (Amersham, MO), and a mixture of primers specific
to each gene present in the array. All probes used had 5 to
10 × 106 cpm and the difference between control and
experimental probes in each assay was less than 10%.
cDNA were hybridized to an Atlas Rat 1.2 Array (#7854-
1) nylon membrane (Clontech, CA). Hybridization and
post-hybridization washes were performed according to
the manufacturer's protocol. The signal was scanned with
a phosphorImager (Molecular Dynamics, CA) after 48 h
of exposure. Control and experimental RNA were always
processed in parallel.
Data analysis
Spot intensities from scanned membranes were analyzed
using the AtlasImage 1.5 software (Clontech, CA). Grids
were orientated manually and adjusted to ensure optimal
spot recognition using AtlasImage's fine tuning tools, dis-
carding spots with dust or locally high background. The
software makes the analysis for background correction
and normalization versus housekeeping genes. It also cal-
culate the ratio and indicates which genes has a ratio > 2
(up regulated), or ratio < 0.5 (down regulated) or 0.5 <
ratio < 2 (equal expression). Gene expression data were
normalized using the Sum method included in the Atlas
Image software. Data points where the expression was not
greater than two standard deviations were discarded. For
the final analysis, data points were the averages from trip-
licates and any non-reproducible data were discarded. The
relative RNA expression with differences between control
and treatment being higher or equal to 2 and lower than
0.5 were considered significantly different [12].
Results
Effect of PGF2α on gene expression in primary decidual 
cells
From the total genes available in the rat 1.2 membrane
arrays, only 20% of the genes were detected in rat primary
decidual cells. Sixty genes were significantly down regu-
lated, whereas only six genes were up regulated by PGF2αReproductive Biology and Endocrinology 2005, 3:3 http://www.rbej.com/content/3/1/3
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(Figures 1 and 2). PGF2α-receptor gene expression was
similar in both control and treated groups. On the other
hand, no differences in the expression of housekeeping
genes such as ribosomal proteins and β-actin could be
detectedin control and PGF2α  treated cells (data not
shown).
Effect of PGF2α on the expression of genes related to the 
extracellular matrix (ECM)
The majority of genes whose expression was affected by
PGF2α in primary decidual cells are genes involved in the
regulation of the ECM. Genes such as gelatinase A
(MMP2), cathepsin L, tissue inhibitor metalloproteinases
2 (TIMP2) and 3 (TIMP3), plasminogen activator
inhibitor1 (PAI1), tissue type plasminogen activator
(tPA), urokinase plasminogen activator (uPA), endothe-
lin 1, calponin, carboxypeptidase D and calponin acidic
were down regulated. The opposite effect was observed for
prostromelysin 53 kDa (proMMP3), plasma proteinase I
alpha and alpha 1 antiproteinase – all of which were sig-
nificantly up regulated by PGF2α (Table 1).
Representative cDNA expression array using mRNA obtained from rat primary decidual cells treated with either PGF2α or  vehicle Figure 1
Representative cDNA expression array using mRNA obtained from rat primary decidual cells treated with either PGF2α or 
vehicle.
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cDNA expression array of rat primary decidual cells treated with PGF2α or vehicle Figure 2
cDNA expression array of rat primary decidual cells treated with PGF2α or vehicle.
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PGF2α regulation of genes related to the proteasome 
protein component system
Messenger RNA encoding proteasome Iota, proteasome
component C2, proteasome subunit RC7-I, 26-S
proteasome regulator and proteasome component C3
were down regulated by PGF2α. Only proteasome compo-
nent C9 was up regulated after PGF2α treatment (Table 2).
PGF2α regulation of genes involved in trafficking and signal 
transduction
The mRNAs encoding for 14-3-3ε and z/δ proteins, and
Annexin IV were down regulated in PDC after PGF2α treat-
ment (Table 3). PGF2α down regulated the expression of
serum glucocorticoid kinase (SGK), casein kinase I, extra-
cellular signal-regulated kinase (ERK-1), male germ cell-
associated kinase (MAK), and Wee tyrosine kinase. PGF2α
also significantly inhibited Crk-associated kinase (CAS),
calcium calmodulin kinase II (CAMKII) and IV (CAM-
KIV), phospholipase C1, and protein phosphatases such
as phosphatase 2A and protein tyrosine phosphatase 1B
(Table 3).
PGF2α effect on the expression of genes associated with 
G-proteins, growth factors, chemokines and cytokines
The 5-hydroxytryptamine receptor 2A (HTR2A), adenos-
ine A2A and A2B receptors (ADORA2A and ADORA2B
respectively), guanine nucleotide-binding protein G α3
subunit (GN-BPG α3), guanine nucleotide-binding pro-
tein α stimulating (GN-BP α stimul.), Rab 11A and gua-
nine nucleotide-binding protein α12 subunit (GN-BP
α12) gene expression were down regulated by PGF2α
(Table 4). The mRNA expression of growth factors such as
bone morphogenetic protein 4 (BMP4), ADP ribosylation
factor 5 and 6 (ADPRF5 and 6 respectively), glia matura-
tion factor β (GMFB), and transforming growth factor β I
(TGF-βI) decreased after PGF2α treatment as well (Table
1). Interferon inducible protein (Table 4) and leukocyte
common antigen (data not shown) were the only
Table 1: Effect of PGF2α on the expression of genes related to the extracellular matrix (ECM).
Gene Bank 
number
Swiss protein 
number
Name Function Ratio % 
decrease
Fold 
increase
U65656 P97581 Gelatinase A Metalloproteinase 0.04 ± 0.02 87.53
Y00697 P07154 Cathepsin L Cysteine protease 0.09 ± 0.05 91.09
L31884 P30121 Tissue inhibitor metalloproteinase 2 (TIMP2) Protease inhibitor 0.05 ± 0.01 95.54
U27201 P48032 Tissue inhibitor metalloproteinase 3 (TIMP3) Protease inhibitor 0.04 ± 0.01 91.95
X63434 P29598 Urokinase type Plasminogen activator (uPA) Serine protease 0.14 ± 0.09 94.86
M24067 P20961 Plasminogen activator inhibitor (PAI) Protease inhibitor 0.09 ± 0.05 91.68
M2367 P19367 Tissue type plasminogen activator (tPA) Serine protease 0.17 ± 0.02 89.90
X71071 Q08290 Calponin Cytoskeleton 0.08 ± 0.004 92.50
U06755 P37397 Calponin, acidic Cytoskeleton 0.24 ± 0.13 76.76
U62897 O35850 Carboxypeptidase D Carboxypeptidase 0.24 ± 0.14 76.48
M64711 P22388 Endothelin 1 Hormone 0.34 ± 0.2 77.48
X02601 P03957 Polypeptide, 53 kDa, growth factor induced Metalloproteinase 2.54 ± 1.04 3
J03552 P14046 Plasma proteinase inhibitor α1-inhibitor III Protease inhibitor 3.64 ± 0.64 4
M32247 P17475 α1 antiproteinase Protease inhibitor 2.45 ± 0.44 3
Ratio = net intensity of PGF2α normalized/net intensity of control normalized, and represent the mean ± SEM of each ratio from separate 
experiments. Ratio > 2 = up regulation; ratio < 0.5 = down regulation; 0.5 < Ratio < 2 = equal expression.
Table 2: PGF2α regulation of genes related to the proteasome component system.
Gene Bank 
number
Swiss Protein 
number
Name Function Ratio % 
decrease
Fold 
increase
D10755 P34062 Proteasome Iota Proteosomal protein 0.07 ± 0.04 93.64
M29859 P18420 Proteasome component C2 Proteosomal protein 0.31 ± 0.15 78.28
U77918 Q63569 26-proteasome component C3 Proteosomal protein 0.39 ± 0.08 61.94
J02897 P17220 Proteasome component C3 Proteosomal protein 0.31 ± 0.02 59.02
D21799 P40307 Proteasome subunit RC7-I Proteosomal protein 0.18 ± 0.01 82.62
X55986 P21670 Proteasome subunit C9 Proteosomal protein 2.32 ± 0.72 3Reproductive Biology and Endocrinology 2005, 3:3 http://www.rbej.com/content/3/1/3
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cytokine and chemokine related genes found significantly
down regulated in response to PGF2α. Conversely, PGF2α
stimulated the expression of basic fibroblast growth recep-
tor factor 1 (bFGRF1) (Table 4).
Discussion
Levels of PGF2α in the uterus need to be under tight con-
trol to avoid interference with the establishment and
progression of pregnancy. Pathophysiological elevations
in PGF2α lead to excessive uterine contractions. Therefore,
PGF2α production must be avoided to maintain a quies-
cent uterus [13]. In this paper we present initial data dem-
onstrating that elevated PGF2α can target the decidua, an
endocrine tissue whose integrity is fundamental for the
success of implantation and for the progression of preg-
nancy. Our results demonstrate that elevated PGF2α down
regulate the expression of decidual genes related to the
proteasome protein component system, those involved in
trafficking and signal transduction and genes associated
with G-proteins, growth factors, chemokines and
cytokines. However, interestingly, the main effect of
PGF2α is related to the turnover and degradation of the
ECM which provides mechanical strength to the tissue.
Thus, in addition to inducing uterine contractions, PGF2α
can have a noxious impact on the success of implantation
and progression of pregnancy, at least in part by deregu-
lating the turnover of the ECM in the decidua.
The largest group of genes down regulated by PGF2α is
directly or indirectly related with the turnover and degra-
dation of the ECM. Genes such as gelatinase A (MMP-2),
TIMP2 and 3 [14,15], cathepsin L [16], carboxypeptidase
D are included in different groups of proteases, and can
directly affect the degradation of the ECM. Carboxypepti-
dase D (CPD) or metallocarboxypeptidase D is a 180-kDa
protein that contains almost three carboxypeptidase-like
domains, a transmembrane domain, and a cytosolic tail.
This gene participates in the processing of proteins trans-
iting the secretory pathway [17]. TGF-β is a key factor that
favours accumulation of collagen, laminin and fibronec-
tin in the ECM [17]. TGF-β can stimulate PAI-1, inhibiting
the protease degradation of the ECM. Other factors
included in the plasminogen/plasmin and fibrinolytic
system, such as tPA, uPA and PAI-1, can participate in the
tissue remodelling of the ECM directly through the
binding to specific receptors, and through the transforma-
tion of the plasminogen precursor bound to the cell sur-
face to plasmin, which is an active serine protease.
Plasmin is able to degrade most of the components of the
ECM either directly or indirectly by the activation of
MMPs. All of the plasminogen/plasmin factors men-
tioned previously participate in the process of deciduali-
zation [19-21].
Endothelin-1 is a peptide characterized as a potent
endothelial cell-derived vasoconstrictor. It is synthesized
as an inactive precursor (preproendothelin) and proc-
essed to a mature active form (endothelin) by zinc
metalloproteinases. The active form, endothelin-1, pro-
motes synthesis of collagen types I and II by fibroblasts,
affects the ECM remodelling and promotes the prolifera-
tion of mesangial cells [21]. Endothelin-1 is also associ-
ated with neovascularization and regulation of blood flow
[22]. This vasoactive factor is also involved in the genesis
of endothelial cells behaviour [22,23].
Annexin IV (ANX4, also called Lipocortin) was differen-
tially down regulated by PGF2α. This protein belongs to a
Table 3: PGF2α regulation of genes encoding proteins involved in trafficking and signal transduction.
Gene Bank 
number
Swiss protein 
number
Name Function Ratio % 
decrease
Fold 
increase
D17615 P97286 14-3-3 z/δ protein Traficking protein 0.14 ± 0.07 86.07
M84416 P29360 14-3-3 Epsilon protein Traficking protein 0.29 ± 0.15 71.63
L01624 Q06226 Serum Glucocorticoid kinase (SGK) Kinase 0.25 ± 0.12 93.49
L07578 Q06486 Casein kinase I δ Kinase 0.29 ± 0.15 72.18
M61177 P21708 Extracellular signal-regulated kinase 1 (ERK1) Kinase 0.29 ± 0.13 66.67
D29766 Q63766 Crk-associated kinase Kinase 0.09 ± 0.06 87.16
M35862 P20793 Male germ cell-associated kinase (Mak) Kinase 0.20 ± 0.11 78.6
D31838 Q63802 Wee tyrosine kinase Cell cycle kinase 0.23 ± 0.12 69.47
M20637 P10688 Phospholipase C δ1 Phospholipase PI kinase 031 ± 0.15 68.24
J04503 P20650 Protein phosphatase 2C α Phosphatase 0.18 ± 0.03 58.87
L12385 P26438 Protein Phosphatase 2A Phosphatase 0.38 ± 0.13 65.91
L13408 P15791 Ca+2/Calmodulin dependent kinase II δ subunit Kinase 0.34 ± 0.12 72.12
M63334 P13234 Ca+2/Calmodulin dependent kinase IV Kinase 0.29 ± 0.15 70.90
M33962 P20417 Protein Tyrosine phosphatase 1B Phosphatase 0.21 ± 0.08 79.77
D38224 P55260 Annexin IV (ANX4) Exocytosis protein 0.14 ± 0.08 86.34
L24810 Q64572 Ca+2/Calmodulin Phosphorylase B Kinase 5.06 ± 2.06 5Reproductive Biology and Endocrinology 2005, 3:3 http://www.rbej.com/content/3/1/3
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family of intracellular proteins that binds membrane
phospholipids in a calcium-dependent manner. Thus, it
can also inhibit phospholipase A2 (PLA2) [24]. ANX4 can
also directly bind glycosaminoglycan (GAG) and can be
localized not only to the cytoplasm but also the cell sur-
face or the extracellular compartment [25]. It has been
proposed that ANX4 could affect the mobilization of dif-
ferent substrates involved in the regulation of the ECM.
Moreover, Annexin IV and other annexins can act as lig-
ands for proteoglycans localized on the cell surface, in the
ECM, or in secretory granules [24,25].
Calponin (CaP) has three genetic isoforms, h1, h2 and
acidic calponin, and can be identified by the individual C-
terminal tail sequences. The c-terminal sequences regulate
actin association and the cytoskeleton [26,27]. It is known
that Cap or basic Cap inhibit the actomyosin ATPase in a
calmodulin dependent manner [27]. Basic Cap, by
affecting microtubules assembly, can modify the cytoskel-
eton of the cells, and indirectly, the associated ECM
[27,28]. On the other hand, acidic Cap belongs to the
family of actin-associated proteins. It can interact with F-
actin but not with microtubules, desmin filaments, and
tropomyosin as basic Cap does. These properties suggest
that acidic Cap is functionally distinct from basic Cap and
could affect the ECM in a different manner [29].
Pro-stromelysin, α1 antiproteinase, plasma proteinase-Iα
inhibitor, basic fibroblast growth receptor factor 1, phos-
phorylase B and proteasome component C9 were the only
genes up regulated by PGF2α in PDC. Pro-stromelysin is a
53 kDa peptide and a pro-MMP3 precursor and is directly
related with the ECM regulation [30]. Plasma proteinase
1α inhibitor belongs to a major group of proteins that
includes  α2-macroglobulin [31], an important protein
secreted by the decidual cells which has a critical role in
the control of implantation [31]. Growth factor receptors,
such as bFGRF, are part of a multigene family of structur-
ally related factors (FGFs 1 to 9), some of which bind
heparin sulphate proteoglycans that are components of
the ECM [32]. bFGRFs as well as bFGF are also temporally
and spatially present in the pregnant rat uterus [33-35].
Another member of the TGFβ superfamily expressed in
the uterus during early implantation and down-regulated
by PGF2α was BMP4, a gene which appears to be involved
in specific stages of embryo development and is [36].
Proteasome component system proteins, such as proteas-
ome Iota, proteasome component C2, proteasome subu-
nit RC-7 I, 26 S-proteasome and proteasome component
C3 were down regulated by PGF2α. Proteosomal compo-
nent systems are the main non-lysosomal proteolytic
structures of the cells that participate in the elimination of
abnormal proteins, short half-life proteins, and proteins
controlling cell cycle [37]. During the process of cell dif-
ferentiation, the level of proteasome expression and its
localization varies. The proteasomal proteins can be inter-
mediaries of ECM by contributing to the modulation of
the cell cycle through the induction of proteasomal degra-
dation of cyclin dependent kinase 2. Cell attachment to
ECM components, such as fibronectin (FN), does not
affect p21 mRNA levels, but the stability of the p21
Table 4: Effect of PGF2α on the expression of genes associated with G-proteins, growth factors, chemokines and cytokines.
Gene Bank 
number
Swiss protein 
number
Name Function Ratio % 
decrease
Fold 
change
X52498 P17246 Transforming Growth Factor β1 Growth factor 0.33 ± 0.2 72
M60921 P27049 Antiproliferative B-cell translocation gene 2 (BTG2) Growth factor 0.28 ± 0.15 51
X61381 P26376 Interferon-induced protein Chemokine 0.25 ± 0.14 56
L11586 Q64604 Leukocyte common antigen Intracell. phosphatase 0.07 ± 0.02 83
Z22607 Q06826 Bone Morphogenetic protein 4 (BMP4) Growth factor 0.34 ± 0.17 78
L12384 P26437 ADP Ribosylation factor 5 Intracellular transducer 0.02 ± 0.008 67
L12385 P26438 ADP Ribosylation factor 6 Intracellular transducer 0.18 ± 0.07 83
Z11558 Q63228 Glia maturation factor β (GMFB) Growth factor 0.17 ± 0.07 83
M30705 P14842 5-hydroxytryptamine receptor 2A (HTR2A) G proteins 0.06 ± 0.03 93
S47609 P30543 Adenosine A2A receptor (ADORA2A) G proteins 0.13 ± 0.08 87
M91466 P29276 Adenosine A2B receptor (ADORA2B) G proteins 0.17 ± 0.07 83
M20713 P08753 Guanine nucleotide-binding protein G α3 subunit G proteins 0.22 ± 0.14 78
M17525 P04894 Guanine nucleotide-binding protein α stimulating G proteins 0.24 ± 0.13 75
M75153 P24410 Rab-11A G proteins 0.18 ± 0.11 82.
D85760 Q63210 Guanine nucleotide-binding protein α12 subunit G proteins 0.15 ± 0.09 85
D12498 Q04589 Basic Fibroblast Growth Receptor factor 1 Growth factor 2.32 ± 1.07 3Reproductive Biology and Endocrinology 2005, 3:3 http://www.rbej.com/content/3/1/3
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protein decreased [36]. Kinase activities such as ERKs, cal-
cium/calmodulin kinase II and IV, SGK, and casein kinase
can affect the ECM downstream or upstream [38]. On the
other hand, ECM can regulate the availability of sub-
strates, as well as factors or effectors downstream or
upstream related with different cascades of signal trans-
duction pathways. For example, proteins such as decorin
are components of the ECM in many tissues and appear to
be involved in matrix assembly [39]. Decorin can cause
the rapid phosphorylation of EGF with the concurrent
activation of mitogen-activated kinase protein kinase sig-
nal pathway. Via TGFβ, decorin can interact with the MAP
kinases signal transduction pathways and cross talk with
calcium /calmodulin-dependent kinase II [40], which in
the cDNA array was down-regulated by PGF2α.
Crk-associated substrate (CAS) was down-regulated by
PGF2α and is another gene related to the ECM. Active CAS
can modulate changes in cell motility and gene expression
by the various MAP kinase cascades, and modify the
organization of the actin cytoskeleton [39]. Another gene
down-regulated by PGF2α was SGK, which is a transcrip-
tionally-regulated serine/threonine protein kinase with
45–55% homology to the catalytic domain of Akt/PKB
protein kinase A [40]. Skg is expressed in decidual tissue
and can be activated by the phosphoinositide 3-kinase
pathway (PI3-Kinase) through PDK1-mediated phospho-
rylation [41]. Traficking proteins such as 14-3-3 z/δ and ε
are involved in the regulation of genes related to the ECM
because it can block the activation cascade of signal trans-
duction pathways [42].
Protein phosphatase type 2A (PP2A) was down regulated
by PGF2α. The first and most important point of control of
PP2A is at the transcriptional level. The increase of phos-
phatase activity corresponded with a decrease in the phos-
phorylation of cellular proteins in anchorage-dependent
cells, but much lesser regulated in anchorage-independent
cells [43].
It is well known that members of the proinflammatory
cytokine family can induce MMP expression in numerous
tissues [44]. Also, cytokines and chemokines, such as
interferon inducible protein and leukocyte common anti-
gen, are associated with the local induction of MMP
expression in response to proinflammatory cytokines. The
indirect action of these molecules through MMPs may aid
to generate different changes in the endometrial stroma
during maternal recognition of pregnancy [44]
We have also compared the pattern of gene expression in
rat decidual tissue in vivo on day 12 of pseudopregnancy
(when the decidua undergoes regression) with that of the
PGF2α treatment in rat PDC in vitro (data not shown).
Interestingly, we found a 49% coincidence in the genes
that were down regulated in both experimental situations.
This coincidence suggests a relationship between the
physiological regression and reorganization of the decid-
ual tissue that occurs on day 12 of pseudopregnancy, with
the pattern of gene expression in rat PDC after PGF2α treat-
ment. On the other hand, many of the genes whose
expression was affected by PGF2α in the rat PDC, are
expressed in the decidua during decidualization and
implantation. This suggests a possible connection
between the action of PGF2α and the physiology of the
decidual tissue. Moreover, the ECM is an important
component of the decidualization and implantation proc-
ess. Any modification in its turnover or degradation could
affect the formation of the decidua, blastocyst invasion,
and the timing of decidual regression and reorganization.
It is known that the expression of MMPs/TIMPs plays an
important role in the control of implantation. If PGF2α
silences or decreases the expression of genes related with
the systems aforementioned, it also could affect tissue
remodelling by directly modifying the proteases involved
in this process, or indirectly by affecting the ECM turnover
and degradation, important in the accumulation of a
spongy mass of tissue around each embryo during decid-
ualization [45]. Most probably, many of PGF2α's effects
on the expression of genes involved in ECM turnover are
indirect. Alterations of genes involved in different signal-
ling pathways such as ERK-1, CaMCKII, PLCδ1 and G-pro-
tein subunits may impact the expression of a great
number of transcripts.
In summary, our results show, for the first time, that
pathophysiological concentrations of PGF2α have a severe
impact on the expression of numerous genes associated
with the turnover of the ECM in the rat decidua. Future
investigation should corroborate the differentially regu-
lated genes, at the level of the message, protein, and in
some cases, such as for the metalloproteinases, at the level
of activity of the proteins. These data will contribute to the
design of future studies on a cluster of gene candidates as
targets of PGF2α action in this endocrine tissue.
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